P0CAZ0 AF NFT

Tubulin glycylase 3B

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiebdfcm4fbs4neqbvo4eruslzf2o3yyxsoxet3h2536kao4m3ru4u/metadata.json
IPFS of structure file: 
bafybeiecuxt6qkduraqteutoljyqc3gkqsygigvevgvxqv42of33nj5tuu/AF-P0CAZ0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xBF0D2e107Ce1EcD2C4369B042274201DB719AaAF
First NFT owner address (bech32): 
genesis1huxjuyruu8kd93pknvzzyapqrkm3n240z6jrgl
Current NFT ID #481869 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
481869
Accession (UniProt):
P0CAZ0
Name::
Tubulin glycylase 3B
Experimental Method:
Predicted structure
Sequence source:
TETRAHYMENA THERMOPHILA (STRAIN SB210)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P0CAZ0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P0CAZ0|TTL3B_TETTS Tubulin glycylase 3B OS=Tetrahymena thermophila (strain SB210) OX=312017 GN=TTLL3B PE=1 SV=2 MFSIDIQGKSMSLCDPTSKIKQMQQQQQQLQQGTNNGIQKDQQLPNMIINGNSNSYLNNGSNLQQQAVIQQSNHKQSQIKYNSPLSHQQHHQFKIGHQNKLEYLRQQQAQKYNQIYQLDPQLQQQNQMFQQHQYMQNVQMQQQLLYQGNQEVFPPFNQIANGSAQNSILLQQYLSNNKGQTNNSNRENGGNFHSEQSPKSAAGSVVSGNGSNTQFAANILRNSNIIQQQNEFRFQQIQQTHQLLHSLVQQQPQPLSQQHSNQSSQSSNPQSQSPLPLSISSQQPVISMANYFNQPSQQSNSLFNGQQPTMFNSSENFQQKNILYSCVGNPNNPYNHHINNPYLQEKRYYKSSKLPKIKKENKPQQAFSDIRPSSREKSARFHLAASINTILNQNGSTSVNTQNNENMVQTLKGHSYSAVTEKSNIGQQEVNIPTTSKTQTLIKEHSLTNINSASKENNQVTLASNSNQTSKKAYENLMSAENDEEDKLKCIRYFRYNLGQLLHILGKKEIYFSNLNSKKPIKTFASITQQLGQKHMNLLSKNTINIINKVKKIVATKGKYKYRERFNFLHSAQLKSINYDVRKRLNQIQDKKVLSNTKSKDEEESSDDDETPVKSKSNNQNAVQQTDLAKWKKYNRLDPKTKVFIIKGGYGDLRKALQERGWVENPDYFSPCFDLKWTCKVQDIDYDNLQENQVVNHFDNNQTFTSKYGLARNLRTLIHSENIDVYKFFPRCFDLGDLQEFEDFIENFKVAKAESLVHRFKDMLKNGIESIDDKLELKIRLCNEVASRKFIDFYETVDFIFNYDVLPCVSPEEWEIISKDEFQLDNKKIEFYLERLRSHPTFKHLYYSNSQSQKQHMNKRKNSHRISVNHNHNDPIEEESAQSSTSLKQDSLQRFSSKSQELLDLCNQTLKKSSEKDPQHHLNGYRNIWIVKPNFLSRGRGIKCFNSLDKIMDYVVGKETQFVVQKYIENPLLINNKKFDMRQWAIVQDFCPPRIWFFEECYIRLCSVEHNIDDLNNRFVHLTNNIVQKYNKDAYADKDDLMMSQEQFAQYLKETEGRDVFYEEIQPKLKQMVIQSLKSCQDQVGARKNSMEFIGYDFMIDSNYQPWLIEINSSPSMEYSTSITEELVQRVLQDTTKVIVDYSMAKKGTKKNVDTGGFKLIYKGEKQTKNNKVLASYKK